Jakub Porzycki / NurPhoto / Getty Images
One quarter into 2025, CVS Health (CVS) has gained the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year.
CVS’s gains were mostly made in the months leading up to, and immediately following, the company’s fourth-quarter results. In February, the health insurance giant and pharmacy giant reported revenue and adjusted earning per share (EPS) better than expected. The positive results may have given investors hope that the new CEO David Joyner would be able to turn things around. Joyner assumed his position in October.
CVS Stock is Down from Last Year
CVS is still down despite its strong start of the year. Shares of CVS lost more than 40% of their value in 2024 due to a difficult year for sales at its pharmacies, and increased medical costs within its health insurance division. In October, it was reported that the company might separate its Aetna health-insurance operations from its pharmacies.
According to Visible Alpha, the consensus analyst price target for CVS is around $73. This is about 8% higher than its closing price on Monday of $67.75. Visible Alpha tracks 13 CVS analysts. Of those, 11 rate the stock as “buy” or similar.
